The Endocrine Society has released a new clinical practice guideline for the primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk.
Read More »Vitamins E and C Supplements Not Effective For Prevention of Cardiovascular Disease
Neither vitamin E nor vitamin C supplements reduced the risk of major cardiovascular events in a large, long-term study of male physicians, according to a new study.
Read More »Aspirin: Should It Be Used for Primary Prevention in Diabetics?
A new study has found no evidence that aspirin or antioxidants are of any benefit in the primary prevention of cardiovascular events in diabetic patients with asymptomatic peripheral arterial disease (PAD)
Read More »Type 1 Diabetes Prevention with Early Insulin a Bust
Insulin therapy doesn’t prevent type 1 diabetes in genetically high-risk infants showing early signs of the autoimmune disease, researchers found.
Read More »Ten Dollars Per Patient Disease Prevention Program Could Save 16 Billion/Yr
Community-based health programs aimed at diet, exercise, smoking prevention and other known risk factors for chronic diseases could cut health-care costs in the United States by $16 billion a year, at a cost of 10 dollars per patient/year, a new report says.
Read More »ADA: Diabetes Prevention Hopes Revived for Thiazolidinedione
Pioglitazone (Actos) may prevent or delay progression to diabetes for patients with pre-diabetes by 81%, researchers found.
Read More »Aspirin for The Prevention of Diabetes
Aspirin-like compounds (salicylates) can claim another health benefit: increasing the amount of insulin produced by otherwise healthy obese people. Obesity is associated with insulin resistance, the first step toward type 2 diabetes.
Read More »Diabetes Prevention, Care, and Education Need To Be Targeted To Men and Women Differently
Women had higher expectations of the benefits of self-management along with more depressive symptoms
Read More »Candesartan Is Better Than Amlodipine for Diabetes Prevention
Candesartan and amlodipine are similarly effective in preventing cardiovascular events in high-risk hypertensive patients, the results of a study suggest. However, candesartan is more effective for the prevention of new-onset diabetes.
Read More »Prevention in the “Real World”: One-year Results of the GOAL Implementation Trial
A lifestyle implementation trial was designed for the primary care setting. The goal was to determine whether findings from the Finnish Diabetes Prevention Study (DPS),[1] which demonstrated a 58% reduction in diabetes with lifestyle intervention, could be replicated in a real-world clinical setting.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.